#13D SYSTEMS Investor Presentation May 2022 ©2022 3D Systems, Inc. | All Rights Reserved. 3D SYSTEMS#22 Forward Looking Statements Certain statements made in this presentation that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward looking statements can be identified by terms such as "believes," "belief," "expects," "may," "will," "estimates," "intends," "anticipates" or "plans" or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management's beliefs, assumptions and current expectations and may include comments as to the company's beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings "Forward-Looking Statements" and "Risk Factors" in the company's periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law Further, we encourage you to review "Risk Factors" in Part 1 of our Annual Report on Form 10-K and Part II of our Quarterly Reports on Form 10-Q filed with the SEC as well as other information about us in our filings with the SEC. These are available at www.SEC.gov. ©2022 3D Systems, Inc. | All Rights Reserved.#3Purpose Statement We are the leaders in enabling additive manufacturing solutions for applications in growing markets that demand high reliability products. ©2022 3D Systems, Inc. | All Rights Reserved.#44 Investment Thesis 3D Differentiators 01 02 Relentless AM application focus in high value markets Broadest range of hardware (metal and polymer), software and materials 03 Scale to support customer needs from inception to fleet production Large and growing AM Market Serviceable Market 1 ~$6 billion+ Best-positioned AM company in the high-growth markets we serve 2021 Revenue² $544m 1. Company estimates 2. Adjusted for divestitures ©2022 3D Systems, Inc. | All Rights Reserved.#55 Company Rebirth for an Even Stronger Future 1986-2020 4 Non-Core Businesses (Exited) Printers July 2020 Focus Materials High Value Growth Software 2021 and Beyond Industrial Solutions Healthcare Solutions Markets with Significant Barriers to Entry 。 Bioprinting (Laboratories) 。 Regenerative Medicine (Humans) Reorganized, Lean, Focused and Growing Excellent Balance Sheet to Support Future Growth Investments ©2022 3D Systems, Inc. | All Rights Reserved.#66 Strong Executive Leadership Team Jeff Graves President and Chief Executive Officer Wayne Pensky Interim Chief Financial Officer Reji Puthenveetil Executive Vice President, Industrial Solutions Menno Ellis Executive Vice President, Healthcare Solutions David Leigh Chief Technology Officer, Additive Manufacturing Chuck Hull Chief Technology Officer, Regenerative Medicine Andrew Johnson Chief Legal Officer Phyllis Nordstrom Chief People, Culture and Compliance Officer ©2022 3D Systems, Inc. | All Rights Reserved.#77 Who We Are and Who We Serve 1,900+ Employees worldwide 1,000+ 3D Systems Today 20+ Market segments served 80+ Patents issued Application Engineers Largest dedicated sales & service organization Broadest Range of AM Solutions Technologies 7 metal and polymer printing platforms 2 major bioprinting platforms 130+ Production Materials Most extensive software platforms Delivering Value to our Customers 20,000+ Production printers active today 35,000+ Printers sold over time 30,000+ each Customers served year 4,800+ Tons of proprietary materials consumed per year 1,000,000+ Parts per day printed with our technology Deepest Experience with Production Requirements ©2022 3D Systems, Inc. | All Rights Reserved.#8Advantages of Additive Drive Industry Growth Why Additive? 0-25mm 0.001mm 1756 01 Design Flexibility 03 Mass Customization 02 Low Volume Parts & Faster Product Cycles 04 Supply Chain Flexibility $15 3D Printing Market Size ($B)1 $45-50 2021 2022 2023 2024 2025 2026 8 1. Market includes hardware, software, materials and printing services. Median of estimates by Markets & Markets, Grandview Research, Fortune Business Insights, Allied Market Research, Emergen Research, Arizton, Guggenheim and Wohlers ©2022 3D Systems, Inc. | All Rights Reserved.#99 Additive Manufacturing is Transforming Existing Industries... Aerospace & Defense Automotive Healthcare Low Volume Interior Components Light-weighting & Complex Geometries for Structural Components Lower Cost & Faster Custom Tooling Maintenance & Repair Operations Faster Product Development Tooling Aids Complex Geometries for Strength & Cooling Capabilities Custom Parts years t Patient Specific Devices & Implants Digital Dentistry Customized Surgical Planning Assistive Technologies ©2022 3D Systems, Inc. | All Rights Reserved.#1010 And Creating Entirely New Ones... Bioprinting for Laboratory Applications Regenerative Medicine for Human Applications Academic Labs for the Study of Regenerative Medicine (printers & consumables for research) Three-dimensional vascularized cell structures for the development of new drug therapies Cellular samples for development of skin care products Solid human organs to address critical illness and extend life (lungs, livers, kidneys, other) Printed human tissues to address damage induced by trauma, disease, or genetic defects (arteries, bones, soft tissue, skin, etc) ©2022 3D Systems, Inc. | All Rights Reserved.#1111 Leading and Differentiated in the Market Application expertise and advanced manufacturing proving grounds Robust range of technologies in polymers and metals Scale and footprint to serve global organizations Software to manage additive manufacturing environment Materials options to handle range of customer requirements Larger Competitors Point Solutions ©2022 3D Systems, Inc. | All Rights Reserved. SOME SOME LIMITED SOME LIMITED#1212 Our Strategic Focus Purpose Deliver leading additive solutions for industrial and healthcare applications 8 Business Strategy Enhance core Healthcare and Industrial businesses & expand Software and RegMed Grow Gross Profit Faster Than Revenue Execution Strategic Focus New Solution Revenue Recurring Revenue Manufacturing Excellence Design Innovate | Launch Materials Service | Software Cost Quality | Delivery Culture Candor Focus Speed Innovation Efficiency Accountability ©2022 3D Systems, Inc. | All Rights Reserved.#1313 Most Comprehensive Product Portfolio in the Industry 9 Application Engineering Hardware 80+ Printer Platforms 10 Software Solutions Services Application Solution 37 Printer Models Software Customer Engagement ©2022 3D Systems, Inc. | All Rights Reserved. Materials Application Engineers 130+ Materials#1414 Our Solutions Approach Leverages Our Significant Scale مهمه A Explore Strategic consulting to identify customer needs Innovate Joint applications development and design for additive Develop QA and process characterization from pre-prototype through prototype Validate Training, validation, and certification Produce Production and manufacturing services Application Engineers Multiple Print Multiple Materials Technologies Options Software For Simulation Optimization and Production Management ©2022 3D Systems, Inc. | All Rights Reserved. Certification Experts & Experience Scale Scale up and technology transfer Advanced Mfg "Proving Grounds" Global Installation and Technical Support#1515 Capabilities to Solve Problems in Multiple Large Segments Automotive RODIN LUCID CAR S DBWT ALPINE F1 TEAM Aerospace AIRBUS GENERAL ATOMICS eesa AERONAUTICAL Manufacturing ASML JABIL WILTING nLIGHT Healthcare rms IGNITE Bioprinting United Therapeutics CORPORATION ORTHOPEDICS דוווו Paragon Medical BWH Massachusetts Institute of Technology Imperial College London ETH ZÜRICH ©2022 3D Systems, Inc. | All Rights Reserved.#1616 Advancing Innovation Through Our Culture TIPP People Advancing innovation through our people Diversity & Inclusion Vison → Innovating for a Sustainable World G F Climate Developing solutions to use resources responsibly Reduce Energy Waste Implementing actions to reduce and eliminate waste Reduce Waste Safety Talent Talent Development Clean Sources Climate Eco-Friendly Materials Modularization ©2022 3D Systems, Inc. | All Rights Reserved. Waste Reuse & Recycle#1717 Strong Progress Towards Long Term Goals in 2021 $544M 2021 FY Revenue 1 32% / 17% Revenue growth versus 2020 and 20191 Divestitures created a focused business positioned for success Revenue outperformed 2020 and pre-pandemic 2019 Gross margin improvements reflects outstanding execution of sales and supply chain Healthy EBITDA reflects revenue growth combined with 2020 business restructuring $56M 43.0% 2021 FY Gross Margin 1 2021 Adjusted-EBITDA 1 $66M Adjusted EBITDA Improvement vs 2020 1 1. Adjusted for divestitures and Non-GAAP ©2022 3D Systems, Inc. | All Rights Reserved.#1818 Balanced and Resilient Revenue Profile 2021 Recurring Revenue¹ 36% 1. Adjusted for divestitures 64% 2021 Segment Revenue¹ ■Recurring ■Healthcare 50% 50% Non-Recurring Industrial ~2/3rd of revenue is recurring, primarily driven by materials, services and software businesses ©2022 3D Systems, Inc. | All Rights Reserved. D#1919 Recurring Revenue Business Model Creates Value Multiple opportunities to drive lifetime revenue Production applications Software Enhanced services Materials 1X ~4X Printers Software Services Materials Total Average Single Printer Lifetime Revenue ©2022 3D Systems, Inc. | All Rights Reserved.#2020 Scale Fuels Growth Distribution of Customer Fleet Size Number of Printers by Size of Customer Fleet¹ >8,500 1 >7,000 >3,500 53% >1,500 customers >400 customers 2-4 Number of printers owned 5+ 11% 5-YR CAGR of Fleet Customers 2 1. Based upon supported printers under service contracts 2. Defined as accounts with three or more printers ©2022 3D Systems, Inc. | All Rights Reserved. Distribution of 2021 Printer Sales 47% New Customer Existing Customer#21Long-Term Financial Targets Growth Drivers Expanding market opportunities drive printer sales Growth of software to manage end-to-end: design, print and production management Materials/services consumption Margin Improvements Driven By Printer standardization to reduce COGS Mix shift to high margin software offerings Scale leverage from supply chain, R&D and SG&A 2027 Targets Revenue $1 Billion Gross Margin 50% R&D 10% Non-GAAP SG&A¹ 20% Adjusted EBITDA 1,2 20% Percentages of Revenue 21 Note: Business model target excludes contribution from regenerative medicine initiatives 1. See "Presentation of Information" in Appendix for a description of non-GAAP SG&A and Adjusted EBITDA 2. Depreciation is expected to be 3-4% of revenue. The addback of depreciation is not specifically included in the adjusted EBITDA target of 20% and provides contingency to meet the target. ©2022 3D Systems, Inc. | All Rights Reserved.#2222 Why 3D Systems? ☑ K Relentless AM application focus in high value markets Focused business + strong balance sheet to support growth Demonstrated double-digit revenue growth Targeting $1B revenue in 5 years Expanding margins through scale, mix, refreshed product portfolio ©2022 3D Systems, Inc. | All Rights Reserved.#23Thank You Find out more at www.3dsystems.com ©2022 3D Systems, Inc. | All Rights Reserved. 3D SYSTEMS#24905 Appendix 24 @2022 3D Systems, Inc. | All Rights Reserved#2525 Presentation of Information 3D Systems reports its financial results in accordance with GAAP. Management also reviews and reports certain non-GAAP measures, including: non-GAAP revenue, non-GAAP Gross profit, non-GAAP Gross profit margin, non-GAAP SG&A, adjusted EBITDA and adjusted EBITDA Margin. Non-GAAP revenue is defined in this presentation as reported revenue less revenue from businesses divested in 2021. These non-GAAP measures exclude certain special items that management does not view as part of 3D Systems' underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results. Management believes that the non-GAAP measures provide useful additional insight into underlying business trends and results and provide a more meaningful comparison of period-over-period results. Additionally, management uses the non- GAAP measures for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. 3D Systems' non-GAAP measures are not calculated in accordance with or as required by GAAP and may not be calculated the same as similarly titled measures used by other companies. These non-GAAP measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. Adjusted EBITDA, defined as net income, plus income tax (provision)/benefit, interest and other income/(expense), net, stock-based compensation expense, amortization of intangibles, depreciation expense and other non-recurring and/or non-cash items all as described above, is used by management to evaluate performance and helps measure financial performance period-over-period. 3D Systems does not provide forward-looking guidance for certain measures on a GAAP basis. The company is unable to provide a quantitative reconciliation of forward-looking non-GAAP SG&A and Adjusted EBITDA to the most directly comparable forward-looking GAAP measures without unreasonable effort because certain items, including legal, acquisition expenses, stock-compensation expense, intangible amortization expense, restructuring expenses, and goodwill impairment, are difficult to predict and estimate. These items are inherently uncertain and depend on various factors, many of which are beyond the company's control, and as such, any associated estimate and its impact on GAAP performance could vary materially. ©2022 3D Systems, Inc. | All Rights Reserved. D#2626 Unaudited Reconciliation of Prior Years Revenue Excluding Divestitures, 2019-2021 (non-GAAP) (in millions) Revenue Healthcare 2019 2020 2021 Industrial Total Revenue 244.5 246.4 306.2 391.9 310.8 309.4 636.3 557.2 615.6 Revenue From Divestitures: Healthcare 53.2 50.5 31.8 Industrial 118.1 94.1 39.9 Total Revenue 171.1 144.6 71.6 Total Revenue (Excl. Divest.): Healthcare 191.3 195.9 274.4 Industrial 273.8 216.7 269.5 Total Revenue (Excl. Divest.): $ 465.1 $ 412.6 $ 543.9 ©2022 3D Systems, Inc. | All Rights Reserved.#2727 Unaudited Reconciliations of GAAP to Non-GAAP measures For the year ended December 31, 2020 (in millions, except per share data) 2020 Amortization, 2020 Legal, acquisition stock-based GAAP and divestiture - compensation & other Cost optimization plan related (1) Impairment of cost-method investments Product end of life adjustment Goodwill impairment Non-GAAP Revenue Gross Profit Gross Profit Margin $ 557.2 $ $ $ $ $ $ $ 557.2 223.4 0.4 0.4 2.2 10.9 237.2 40.1% 42.6% Operating expenses 342.3 (33.0) (4.1) (20.0) (48.3) 236.9 Operating income (loss) (119.0) 33.4 4.5 22.3 10.9 48.3 0.3 Interest and other income (24.4) 1.0 14.1 2.2 (7.2) (expense), net Net income (loss) Net (loss) EPS-basic Net (loss) EPS- diluted SSS $ (149.6) $ 34.4 $ 18.6 $ 22.3 $ 2.2 $ 10.9 $ 48.3 $ (13.1) $ (1.3) $ 0.3 $ 0.2 $ 0.2 $ 0.0 $ 0.1 $ 0.4 $ (0.1) $ (1.3) $ 0.3 $ 0.2 $ 0.2 $ 0.0 $ 0.1 $ 0.4 $ (0.1) Weighted Average Shares - basic Weighted Average Shares - diluted 117.6 117.6 117.6 117.6 ©2022 3D Systems, Inc. | All Rights Reserved.#2828 Unaudited Reconciliations of GAAP to Non-GAAP measures For the year ended December 31, 2021 (in millions, except per share data) 2021 Amortization, 2021 Legal, acquisition GAAP stock-based compensation & and divestiture - related(2) Cost optimization plan Product end of life adjustment Non-GAAP other Revenue Gross Profit Gross Profit Margin Operating expenses 615.6 $ $ 615.6 263.8 0.5 0.2 264.5 42.8% 43.0% 296.8 Operating income (loss) (33.1) (64.4) 64.9 (16.3) (1.4) 214.7 16.3 1.5 0.2 49.8 Interest and other income 352.6 (353.8) (1.3) (expense), net Net income (loss) $ 322.1 $ 64.9 $ (331.9) $ 1.5 $ 0.2 $ Net income EPS - basic $ 2.6 $ 0.5 $ (2.7) $ 0.0 $ Net income EPS - diluted 2.5 $ 0.5 $ (2.6) $ 0.0 $ . etes est 56.6 $ 0.5 $ 0.4 Weighted Average Shares - basic Weighted Average Shares - diluted 122.9 126.3 ©2022 3D Systems, Inc. | All Rights Reserved. 122.9 126.3#2929 Non-GAAP Operating Income to Adjusted EBITDA Reconciliation For the years ending December 31, 2021 and 2020 Revenue Non-GAAP Operating Income Depreciation Adjusted EBITDA Adjusted EBITDA Margin 2021 2020 $ 615.60 $ 557.20 49.8 0.3 24.3 28.4 $ 74.1 $ 28.7 12.0% 5.2% ©2022 3D Systems, Inc. | All Rights Reserved.#3030 Reconciliation of GAAP Operating Income to Adjusted EBITDA excluding Divestitures For the years ending December 31, 2021 and 2020 GAAP Operating Income (Loss) plus: Adjustments from GAAP to Non-GAAP less: Operating Income from Divestitures Non-GAAP Operating Income excluding Divestititures Plus: Depreciation excluding divestitures Adjusted EBITDA excluding divestitures ©2022 3D Systems, Inc. | All Rights Reserved. 2020 $ (119.0) 119.4 (34.6) 2021 $ (33.1) 82.8 (16.2) $ 33.5 $ (34.2) 23.9 $ (10.3) 22.6 $ 56.1